ArticleLaryngoscope investigative otolaryngology2021

Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomas.

D Bradley Welling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.